MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$67,893K
Accounts receivable, net
of allowance for...
$53,654K
Cash and cash
equivalents
$29,635K
Inventory
$5,515K
Prepaid expenses,
current
$3,642K
Restricted cash, current
$2,091K
Other assets, current
$256K
Property, plant and
equipment, gross
$4,785K
Total current assets
$162,686K
Intangible assets, net
$41,392K
Lease right-of-use
assets, net
$5,373K
Deferred tax assets
$3,830K
Prepaid expenses and
other, long-term
$2,834K
Property and equipment,
net
$187K
Less accumulated
depreciation
$4,598K
Total assets
$216,302K
Total liabilities and
stockholders equity
$216,302K
Total stockholders
equity
$130,340K
Total liabilities
$85,962K
Accumulated deficit
-$1,283,775K
Additional paid-in capital
$1,414,074K
Total current
liabilities
$81,253K
Lease liabilities,
long-term
$4,709K
Accumulated other
comprehensive income
$36K
Common stock - .0001 par
value per share...
$5K
Accrued expenses,
current
$50,031K
Current portion of
long-term debt
$22,523K
Accounts payable
$5,056K
Post-marketing commitment
liability
$2,187K
Lease liabilities,
current
$1,314K
Other liabilities,
current
$142K
Back
Back
Balance Sheet
source: myfinsight.com
PUMA BIOTECHNOLOGY, INC. (PBYI)
PUMA BIOTECHNOLOGY, INC. (PBYI)